Lemaitre Vascular (LMAT) Debt Ratio (2020 - 2021)
Lemaitre Vascular's (LMAT) quarterly Debt Ratio came in at 0.1 in Q2 2021, down 57.41% year-over-year from 0.24 in Q2 2020, and down 18.24% quarter-over-quarter from 0.13 in Q1 2021.
Powered by 
Analysis
Lemaitre Vascular (LMAT) Debt Ratio (2020 - 2021) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Debt Ratio for 2 consecutive years, with 0.1 the latest figure, recorded in Q2 2021.
- On a quarterly basis, Debt Ratio fell 57.41% year-over-year to 0.1 in Q2 2021; TTM through Jun 2021 was 0.1, a 57.41% decrease from a year earlier, with the FY2020 full-year figure at 0.15, changed N/A from the prior year.
- Debt Ratio was 0.1 for Q2 2021 at Lemaitre Vascular, down from 0.13 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.24 in Q2 2020 and troughed at 0.1 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 0.30 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 0.30 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 0.31 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 0.28 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 0.04 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.13 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 0.20 |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.13 |
| Dec 31, 2020 | 0.15 |
| Sep 30, 2020 | 0.22 |
| Jun 30, 2020 | 0.24 |